TGFB1 and hereditary hemorrhagic telangiectasia: More than 80% of HHT patients carry a mutation in Endoglin (ENG; HHT1) or Activin receptor-like kinase 1 (ACVRL1; HHT2) genes that code for receptors of the transforming growth factor β (TGF-β) superfamily.